Definitive Contract 75N93021C00050
Award Date
8/27/21
Potential Completion Date
5/31/23
Potential Value
$300K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Giner Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Auburndale, MA 02466, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
22
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $299,633 Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Giner Inc., a Boston-based research and development firm. The contract is for the development of a "smartphone-integrated point-of-care sensor for rapid and sensitive detection of malaria in low-resource applications." Giner Inc. has experience delivering technology...
This Small Business Innovation Research Phase I contract was awarded by the National Institutes of Health National Institute of Allergy and Infectious Diseases to Giner Inc. for $299,949. The contract calls for the development of a low-cost and robust nucleic acid sensor instrument that can rapidly and accurately identify the presence of dimorphic fungal species to yield early and definitive diagnosis of endemic fungal diseases such as histoplasmosis and coccidioidomycosis. The contract responds...
This is a $299,966.00 firm fixed-price SBIR Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Giner Inc., a small business research and development firm based in Boston. The contract is for the development of point-of-care monitoring technologies to assess adherence to antiretroviral HIV therapy. The original contract opportunity was part of a broader SBIR solicitation from the National Institutes of Health (NIH) and Centers for Disease Control...
This is a $1,099,888.52 Firm Fixed Price definitive contract awarded by the Defense Health Agency (DHA) to Giner Inc., a Boston-based research and development firm focused on electrochemical technologies. The contract is for a STTR Phase II effort titled "Rapid and Reprogrammable Assay for Multiplexed Gene Detection." This Small Business set-aside contract supports the DHA's medical research and development mission, with an ultimate completion date of November 13, 2025. Giner Inc....
This contract is an SBIR Phase I award from the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Giner Inc., a Boston-based research and development firm. The contract, valued at $149,983.00, is for a Small Business Innovation Research (SBIR) project and does not have a set-aside designation. Giner Inc. is a for-profit, subchapter S corporation that specializes in developing cutting-edge electrochemical technologies, including those for clean energy,...
The Department of Health and Human Services National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases awarded a Cost Plus Fixed Fee definitive contract to Giner Inc., a Boston-based research and development firm, for RESEARCH AND DEVELOPMENT FACILITIES. The contract has a potential value of $1,500,000.00 and does not have a set-aside designation. Giner Inc. is a for-profit Subchapter S Corporation that has extensive experience in developing cutting-edge...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $149,875.00 firm-fixed-price purchase order contract to Giner Inc., a small business subchapter S corporation based in Boston, for the development of an advanced sensor for rapid, on-site detection of Legionella contamination in water. The contract has a completion date of June 30, 2021. Giner Inc. is a research and development firm that has previously received federal contracts and grants from...
This is a federal contract award from the Centers for Disease Control and Prevention (CDC) to Giner Inc., a research and development firm based in Massachusetts. The contract, valued at $149,992.02, is for "critical functions" and has a set-aside designation for small businesses. The contract is a firm fixed-price purchase order with a completion date of May 22, 2017. Giner Inc. is a technology company that has previously secured contracts and grants from various federal agencies,...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian agency, to Giner Inc., a small business research and development firm based in Auburndale, Massachusetts. The $299,749 firm-fixed-price contract is for biomedical research and development work. Giner Inc. has a history of securing federal contracts and grants from agencies like NASA, the Department of Defense, and the Department of Energy to develop advanced...
This $299,889 firm fixed price definitive contract was awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to Esper Biosciences Inc. for hepatitis C diagnostics using nanopore field-effect sensors. The contract is being performed in Ithaca, NY from September 2021 through September 2023. It falls under a Small Business Innovation Research solicitation issued by the NIH and Centers for Disease Control and Prevention seeking proposals for...